Emerging Safety Science: Workshop Summary (2008)

Chapter: 8 Pharmacovigilance

Previous Chapter: 7 Qualifying Biomarkers
Suggested Citation: "8 Pharmacovigilance." Institute of Medicine. 2008. Emerging Safety Science: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11975.
Page 74
Suggested Citation: "8 Pharmacovigilance." Institute of Medicine. 2008. Emerging Safety Science: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11975.
Page 75
Suggested Citation: "8 Pharmacovigilance." Institute of Medicine. 2008. Emerging Safety Science: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11975.
Page 76
Suggested Citation: "8 Pharmacovigilance." Institute of Medicine. 2008. Emerging Safety Science: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11975.
Page 77
Suggested Citation: "8 Pharmacovigilance." Institute of Medicine. 2008. Emerging Safety Science: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11975.
Page 78
Suggested Citation: "8 Pharmacovigilance." Institute of Medicine. 2008. Emerging Safety Science: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11975.
Page 79
Suggested Citation: "8 Pharmacovigilance." Institute of Medicine. 2008. Emerging Safety Science: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11975.
Page 80
Suggested Citation: "8 Pharmacovigilance." Institute of Medicine. 2008. Emerging Safety Science: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11975.
Page 81
Suggested Citation: "8 Pharmacovigilance." Institute of Medicine. 2008. Emerging Safety Science: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11975.
Page 82
Suggested Citation: "8 Pharmacovigilance." Institute of Medicine. 2008. Emerging Safety Science: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11975.
Page 83
Suggested Citation: "8 Pharmacovigilance." Institute of Medicine. 2008. Emerging Safety Science: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11975.
Page 84
Suggested Citation: "8 Pharmacovigilance." Institute of Medicine. 2008. Emerging Safety Science: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11975.
Page 85
Suggested Citation: "8 Pharmacovigilance." Institute of Medicine. 2008. Emerging Safety Science: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11975.
Page 86
Suggested Citation: "8 Pharmacovigilance." Institute of Medicine. 2008. Emerging Safety Science: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11975.
Page 87
Suggested Citation: "8 Pharmacovigilance." Institute of Medicine. 2008. Emerging Safety Science: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11975.
Page 88
Suggested Citation: "8 Pharmacovigilance." Institute of Medicine. 2008. Emerging Safety Science: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11975.
Page 89
Suggested Citation: "8 Pharmacovigilance." Institute of Medicine. 2008. Emerging Safety Science: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11975.
Page 90
Suggested Citation: "8 Pharmacovigilance." Institute of Medicine. 2008. Emerging Safety Science: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11975.
Page 91
Suggested Citation: "8 Pharmacovigilance." Institute of Medicine. 2008. Emerging Safety Science: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11975.
Page 92
Next Chapter: 9 Integration
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.